ACE inhibitors and ARBs in chronic heart failure: the established, the expected, and the pragmatic

This publication has 54 references indexed in Scilit:

• A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
  New England Journal of Medicine, 2001
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
  Published by Elsevier ,1997
• Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor
  The American Journal of Cardiology, 1994
• Early treatment with captopril after acute myocardial infarction.
  Heart, 1993
• Enalapril as initial and sole treatment in severe chronic heart failure with sodium retention
  International Journal of Cardiology, 1990
• Low-dose enalapril in severe chronic heart failure
  Cardiovascular Drugs and Therapy, 1989
• Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
  New England Journal of Medicine, 1986
• Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.
  Circulation, 1984
• CLINICAL EXPERIENCE WITH CHLOROTHIAZIDE
  The Lancet, 1958